Pregled bibliografske jedinice broj: 1200364
Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis
Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis // Annals of the rheumatic diseases, 80 (2021), Suppl 1
online, 2021. str. 1199-1199 doi:10.1136/annrheumdis-2021-eular.4164 (ostalo, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1200364 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Neutrophil-to-lymphocyte ratio, platelet-to-
lymphocyte ratio and mean platelet volume in lupus
nephritis
Autori
Knežević, Tamara ; Padjen, Ivan ; Bulimbašić, Stela ; Ćorić, Marijana ; Ivković, Vanja ; Laganović, Mario ; Anić, Branimir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Annals of the rheumatic diseases, 80 (2021), Suppl 1
/ - , 2021, 1199-1199
Skup
European congress of rheumatolog (EULAR 2021)
Mjesto i datum
Online, 02.06.2021. - 05.06.2021
Vrsta sudjelovanja
Ostalo
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
lupus nephritis ; systemic lupus erythematosus ; complete blood cell count
Sažetak
Background: A number of blood count parameters are associated with inflammatory and autoimmune diseases. There is discordant evidence whether neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV) might reflect inflammatory response and have prognostic value in SLE patients. However, the studies examining the potential role of these markers in LN are missing. Objectives: To examine NLR, PLR and MPV at the time of biopsy in patients with LN and evaluate their association with prognosis. Methods: In this retrospective study we analyzed the demographic, histologic, laboratory and clinical characteristics of patients with biopsy- proven LN diagnosed between 2011 and 2020. All patients met the 1997 revised American College of Rheumatology classification criteria for SLE. Complete remission was defined as proteinuria <0.5 g/day and serum creatinine within 10% from baseline, and partial remission as more than 50% reduction in proteinuria to sub-nephrotic levels and serum creatinine within 10% from baseline. Results: We have included 55 patients (80% women) with biopsy-proven LN (age at biopsy 38±13 years). On renal histology, one patient was class I LN, two patients were class II, 7 were class III, 5 were class III+V, 23 were class IV, two were class IV+V, 11 class VI and 4 had other features. Median baseline NLR was 3.64 (IQR: 1.85, 6.93), PLR was 167 (IQR: 116, 300) and MPV was 10.0 (IQR: 9.2, 10.8). There were no differences in any of the three parameters between different classess of LN (all p>0.05). Eighteen patients achieved complete remission (CR), 16 partial remission and 21 did not achieve remission. None progressed to ESRD and two patients died, both from sepsis. There no differences in NLR, PLR and MPV at the time of biopsy between group which achieved CR/PR vs. no remission (all p>0.05 ; Figure 1 ). We constructed a thorough multivariate regression model which showed that neither NLR, PLR or MPV are predictors of renal remission in LN. Conclusion: NLR, PLR and MPV are not useful prognostic markers in predicting renal remission in LN.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Tamara Knežević
(autor)
Branimir Anić
(autor)
Marijana Ćorić
(autor)
STELA BULIMBAŠIĆ
(autor)
Mario Laganović
(autor)
Vanja Ivković
(autor)
Ivan Padjen
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE